Literature DB >> 2365193

Transforming growth factor beta 1 selectively augments collagen synthesis by human intestinal smooth muscle cells.

M F Graham1, G R Bryson, R F Diegelmann.   

Abstract

Intestinal smooth muscle cells play a major role in the stricture formation that complicates chronic intestinal inflammation, by proliferating and producing collagen. Transforming growth factor beta 1 has been identified as an important inflammatory mediator in the fibrotic response of human tissue to inflammation. To determine whether this mediator might be involved in intestinal fibrosis, the effect of transforming growth factor beta 1 on collagen production and proliferation by human intestinal smooth muscle cells was studied in vitro. Cells in the second passage were grown to subconfluence in medium containing 10% Nu-Serum (Collaborative Research Inc., Bedford, MA), after which the concentration of Nu-Serum was decreased. Forty-eight hours later, transforming growth factor beta 1 was added to the culture medium to achieve concentrations of 1-500 pmol/L. After 24 hours exposure to the transforming growth factor beta 1, cellular collagen synthesis was determined by the uptake of [3H]proline into collagenase-sensitive protein. Transforming growth factor beta 1 caused a 100% increase in collagen production and a 40% increase in noncollagen protein production per cell, reflecting an increase in relative collagen synthesis of 58%. This effect was maximal at a concentration of 10 pmol/L. Epidermal growth factor, by comparison, had no significant effect on relative collagen synthesis. Transforming growth factor beta 1 caused a significant increase in the uptake of methylaminoisobutyric acid, a nonmetabolized amino acid analog, into the cells at 10 pmol/L. However, this effect was small (20% increase) compared with the effect on the uptake of proline into collagen (100% increase) at this concentration. When cell proliferation was examined by the uptake of [3H]thymidine, transforming growth factor beta 1 had no effect, whereas epidermal growth factor (1000 pmol/L) caused a 94% increase. Transforming growth factor beta 1 selectively augments collagen production by human intestinal smooth muscle cells in vitro. This effect is potent and is not related to effects on either cell proliferation or amino acid uptake. These data suggest that transforming growth factor beta 1 has an important role as an inflammatory mediator in the pathogenesis of intestinal fibrosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2365193     DOI: 10.1016/0016-5085(90)91028-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  26 in total

1.  Amelioration of excess collagen IαI, fibrosis, and smooth muscle growth in TNBS-induced colitis in IGF-I(+/-) mice.

Authors:  Sunila Mahavadi; Robert S Flynn; John R Grider; Li-Ya Qiao; Karnam S Murthy; Krystina B Hazelgrove; John F Kuemmerle
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

2.  Longitudinal mechanical tension induces growth in the small bowel of juvenile rats.

Authors:  S D Safford; A J Freemerman; K M Safford; R Bentley; M A Skinner
Journal:  Gut       Date:  2005-04-19       Impact factor: 23.059

3.  Creeping fat in Crohn's disease: travelling in a creeper lane of research?

Authors:  A Schäffler; H Herfarth
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 4.  Production of inflammatory cytokines in the intestinal lamina propria.

Authors:  C Fiocchi
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

5.  Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling.

Authors:  Jurgen J W Mulsow; R William G Watson; John M Fitzpatrick; P Ronan O'Connell
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

6.  Effects of transforming growth factor-beta on collagen synthesis by normal rat kidney epithelial cells.

Authors:  J J Creely; S J DiMari; A M Howe; M A Haralson
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

Review 7.  Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin?

Authors:  Mariabeatrice Principi; Floriana Giorgio; Giuseppe Losurdo; Viviana Neve; Antonella Contaldo; Alfredo Di Leo; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2013-11-15

8.  Endogenous IGF-I and alphaVbeta3 integrin ligands regulate increased smooth muscle hyperplasia in stricturing Crohn's disease.

Authors:  Robert S Flynn; Karnam S Murthy; John R Grider; John M Kellum; John F Kuemmerle
Journal:  Gastroenterology       Date:  2009-09-12       Impact factor: 22.682

Review 9.  Pathogenetic and clinical relevance of cytokines in inflammatory bowel disease.

Authors:  R B Sartor
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

10.  Transforming growth factor-betas and their signaling receptors are coexpressed in Crohn's disease.

Authors:  F F di Mola; H Friess; A Scheuren; P Di Sebastiano; H Graber; B Egger; A Zimmermann; M Korc; M W Büchler
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.